Atre­ca bags $35M B round for next-gen im­muno-on­col­o­gy drug pipeline

Atre­ca out of Red­wood City, CA has round­ed up a $35 mil­lion B round to fund its re­search on the hu­man im­mune sys­tem and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.